Shannon M Dunlay1, Thomas G Allison2, Naveen L Pereira2. 1. Division of Cardiovascular Diseases in the Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Division of Health Care Policy and Research in the Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. Electronic address: Dunlay.Shannon@mayo.edu. 2. Division of Cardiovascular Diseases in the Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND: Reduced exercise tolerance from impaired cardiac output is an important criterion for left ventricular assist device (LVAD) implantation. However, little is known about how exercise capacity changes after LVAD and how changes compare with patients undergoing heart transplantation. METHODS AND RESULTS: We compared changes in cardiopulmonary exercise testing performed pre- and postoperatively in patients who underwent HeartMate II LVAD implantation (n = 25) and heart transplantation (n = 74) at the Mayo Clinic in Rochester, Minnesota, between 2007 and 2012. Preoperatively, patients undergoing LVAD and transplant had markedly reduced exercise time (mean 5.1 minutes [45% predicted] and 5.0 minutes [44% predicted], respectively), low peak oxygen consumption (VO2; mean 11.5 mL · kg · min [43% predicted] and 11.9 mL · kg · min [38% predicted]), and abnormal ventilatory gas exchange (ratio of minute ventilation to carbon dioxide production [VE/VCO2] nadir 39.4 and 37.4). After LVAD and transplant, there were similar improvements in exercise time (mean Δ +1.2 vs. 1.7 minutes, respectively, P = .27) and VE/VCO2 nadir (mean Δ -3.7 vs. -4.2, P = .74). However, peak VO2 increased posttransplant but did not change post-LVAD (mean Δ +5.4 vs. +0.9 mL · kg · min, respectively, P < .001). Most patients (72%) had a peak VO2 < 14 mL · kg · min post-LVAD. CONCLUSIONS: Although improvements in exercise capacity and gas exchange are seen after LVAD and heart transplant, peak VO2 doesn't improve post-LVAD and remains markedly abnormal in most patients.
BACKGROUND: Reduced exercise tolerance from impaired cardiac output is an important criterion for left ventricular assist device (LVAD) implantation. However, little is known about how exercise capacity changes after LVAD and how changes compare with patients undergoing heart transplantation. METHODS AND RESULTS: We compared changes in cardiopulmonary exercise testing performed pre- and postoperatively in patients who underwent HeartMate II LVAD implantation (n = 25) and heart transplantation (n = 74) at the Mayo Clinic in Rochester, Minnesota, between 2007 and 2012. Preoperatively, patients undergoing LVAD and transplant had markedly reduced exercise time (mean 5.1 minutes [45% predicted] and 5.0 minutes [44% predicted], respectively), low peak oxygen consumption (VO2; mean 11.5 mL · kg · min [43% predicted] and 11.9 mL · kg · min [38% predicted]), and abnormal ventilatory gas exchange (ratio of minute ventilation to carbon dioxide production [VE/VCO2] nadir 39.4 and 37.4). After LVAD and transplant, there were similar improvements in exercise time (mean Δ +1.2 vs. 1.7 minutes, respectively, P = .27) and VE/VCO2 nadir (mean Δ -3.7 vs. -4.2, P = .74). However, peak VO2 increased posttransplant but did not change post-LVAD (mean Δ +5.4 vs. +0.9 mL · kg · min, respectively, P < .001). Most patients (72%) had a peak VO2 < 14 mL · kg · min post-LVAD. CONCLUSIONS: Although improvements in exercise capacity and gas exchange are seen after LVAD and heart transplant, peak VO2 doesn't improve post-LVAD and remains markedly abnormal in most patients.
Authors: Ileana L Piña; Carl S Apstein; Gary J Balady; Romualdo Belardinelli; Bernard R Chaitman; Brian D Duscha; Barbara J Fletcher; Jerome L Fleg; Jonathan N Myers; Martin J Sullivan Journal: Circulation Date: 2003-03-04 Impact factor: 29.690
Authors: Tat-Chi Leung; Karla V Ballman; Thomas G Allison; Jean A Wagner; Lyle J Olson; Robert P Frantz; Brooks S Edwards; Joseph A Dearani; Richard C Daly; Christopher G A McGregor; Richard J Rodeheffer Journal: J Heart Lung Transplant Date: 2003-01 Impact factor: 10.247
Authors: Mandeep R Mehra; Jon Kobashigawa; Randall Starling; Stuart Russell; Patricia A Uber; Jayan Parameshwar; Paul Mohacsi; Sharon Augustine; Keith Aaronson; Mark Barr Journal: J Heart Lung Transplant Date: 2006-09 Impact factor: 10.247
Authors: B E Jaski; J Kim; R S Maly; K R Branch; R Adamson; L K Favrot; S C Smith; W P Dembitsky Journal: Circulation Date: 1997-05-20 Impact factor: 29.690
Authors: D G Renlund; D O Taylor; R D Ensley; J B O'Connell; E M Gilbert; M R Bristow; H Ma; F G Yanowitz Journal: J Heart Lung Transplant Date: 1996-01 Impact factor: 10.247
Authors: Melissa A H Witman; Ryan S Garten; Jayson R Gifford; H Jonathan Groot; Joel D Trinity; Josef Stehlik; Jose N Nativi; Craig H Selzman; Stavros G Drakos; Russell S Richardson Journal: JACC Heart Fail Date: 2015-08-12 Impact factor: 12.035
Authors: Julien Guihaire; Francois Haddad; Mita Hoppenfeld; Myriam Amsallem; Jeffrey W Christle; Clark Owyang; Khizer Shaikh; Joe L Hsu Journal: Can J Cardiol Date: 2019-11-09 Impact factor: 5.223
Authors: Susanne E A Felix; Martinus I F Oerlemans; Faiz Z Ramjankhan; Steven A Muller; Hans H Kirkels; Linda W van Laake; Willem J L Suyker; Folkert W Asselbergs; Nicolaas de Jonge Journal: ESC Heart Fail Date: 2021-03-12